Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1470338 | 1.00 | CYP4F2 (0.36) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL1468666 | 1.00 | CYP4F2 (0.36) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL12141036 | 0.86 | CYP4F2 (0.39) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL15115984 | 0.80 | CYP4F2 (0.39) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL1833017 | 0.80 | OPRL1 (0.32) | — | |
| SCHEMBL10326319 | 0.80 | CYP4F2 (0.39) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL10343728 | 0.80 | CYP4F2 (0.39) | CYP4F2CYP4A11NPSR1MAPT | |
| SCHEMBL1835149 | 0.79 | — | — | |
| SCHEMBL2285823 | 0.79 | — | — | |
| SCHEMBL16875398 | 0.77 | GAA (0.41) | CYP4F2CYP4A11NPSR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383574-B2 | Perfume composition | KAO CORPORATION (JP) | 2013-02-26 | — | — | US | disclosed |
| EP-2253695-B1 | PERFUME COMPOSITION | KAO CORP (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20110071070-A1 | PERFUME COMPOSITION | KAO CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-2253695-A1 | PERFUME COMPOSITION | Kao Corporation (JP) | 2010-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071070-A1 | PERFUME COMPOSITION | C5, C1S, C1R | CYP4F2 310/4885CYP4A11 352/4885NPSR1 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.